Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Looking for ways to generate income without capital? Discover innovative strategies to earn money without an initial investment.
25,905 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
A keynote from Nvidia's founder signals a major shift for AI hardware and software. This could change the game for Nv...
A former hedge fund executive assistant goes public with a memoir detailing the grind behind elite money management. ...
As AI reshapes the job market and tuition costs rise, the debate over whether the college degree still worth the cost...
Visa and Mastercard are reportedly pursuing a stablecoin platform with Stripe and Coinbase, a move that could alter h...
Two Nasdaq-100 trackers move in lockstep on performance, but their legal wrappers drive costs and tax implications. H...
Pennsylvania is weighing a tax move that would extend the state's telecom gross receipts tax to digital advertising. ...
CVS Health is leveraging its vast network to tap into the GLP-1 weight-loss wave. This explainers-backed piece breaks...
Finassets unveils a bold overhaul of its crypto affiliate program, boosting first-year partner earnings and locking i...
When a superstar launches a first-of-its-kind anime, money talks as loudly as fans. This article breaks down the fina...
Two pharma giants, two very different growth stories. This guide breaks down why Eli Lilly might be the best growth s...
Strategy's STRC is shaping up as the backbone of a new yield-backed stablecoin ecosystem, with a boosted monthly divi...